Candesartan Cilexetil and Hydrochlorothiazide
NDC 62559-662, Candesartan Cilexetil and Hydrochlorothiazide, tablet, from ANI Pharmaceuticals, Inc..
- Product NDC
- 62559-662
- Status
- Listed
- Labeler
- ANI Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA021093
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62559-662 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CANDESARTAN CILEXETIL32 mg/1
- HYDROCHLOROTHIAZIDE25 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62559-662-90 | 62559066290 | 90 TABLET in 1 BOTTLE (62559-662-90) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/bd8d318d-167a-4b26-935d-265dde3193deNADAC price for package 62559066290
GET /v1/drugs/nadac/62559066290
Use it
Look up 62559-662 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62559-662 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62559-662. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.